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Retinopathy is a microvascular pathology of the neural tissue of the retina (1). A cascade of 
neural degradation often precedes 
vascular lesions, evolving in line with 
a litany of widespread health compli-
cations identifiable in poorly managed 
diabetes (1). Microvascular constric-
tion determines the severity of retinal 
blood flow impediment and promotes 
the proliferation of new blood vessels 
(2). However, such abnormal angio-
genesis may progressively occlude 
vision among patients with retinop-
athy. Perfusion imbalances also initi-
ate widespread vascular constriction, 
which further contributes to retinal 
ischemia (3). Specifically, vascular 
endothelial growth factor, in addi-
tion to a multitude of growth factor 
hormones and proinflammatory cy-
tokines, has been associated with hy-
perglycemia, insulin resistance, and 
retinopathy (4–7). High blood pres-
sure has been implicated in vascular 
endothelial growth factor release, 
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Objective. We evaluated the specific association between muscle-strengthening 
activity (MSA) and accelerometer-assessed physical activity on systemic inflam-
mation among retinopathy patients in the United States.
Methods. Data from the 2005–2006 National Health and Nutrition 
Examination Survey (NHANES) were used to identify 157 retinopathy 
patients between 40 and 85 years of age with complete data on select study 
variables. MSA was assessed via self-report. Participation in moderate-to- 
vigorous physical activity (MVPA) was determined from objective accelerom-
eter data. Systemic inflammation was assessed using C-reactive protein (CRP), 
which was quantified using latex-enhanced nephelometry. Nonproliferative 
retinopathy was determined using Early Treatment Diabetic Retinopathy 
Study grading criteria, as well as objective retinal imaging assessments using 
the Canon Non-Mydriatic Retinal Camera CR6-45NM. Individuals were 
excluded if they had been diagnosed with coronary artery disease, congestive 
heart failure, heart attack, or stroke.
Results. MVPA (β = –0.004, 95% CI –0.007 to –0.001, P = 0.006) but 
not MSA (β = –0.0001, 95% CI –0.002 to 0.001, P = 0.86) was associated 
with lower CRP levels. Additionally, for a more substantive 30 minutes/day 
increase in MVPA, there was a corresponding 0.12 mg/dL decrease in CRP.
Conclusion. In this nationally representative sample of adults, only indi-
viduals who engaged in higher levels of MVPA had lower CRP levels, which 
is indicative of reduced systemic inflammation. MSA was not associated with 
systemic inflammation among this cohort. Our findings suggest that MVPA 
is inversely associated with systemic inflammation among retinopathy patients, 
which is noteworthy because increased systemic inflammation may facilitate 
retinopathic severity.
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vessel derangement, and increase in 
mitochondrial free radicals and isch-
emia (8,9). Mitochondrial function is 
at pronounced risk under conditions 
of hyperglycemia. If retinal mitochon-
dria are damaged, optimal cellular 
activity may be halted indefinitely; 
thus, DNA will also be irreversibly de-
stroyed (10). It is well established that 
retinopathy is exacerbated by several 
pathological biochemical interactions, 
wherein critically insidious character-
istics of retinopathic development 
may be illuminated by biomarkers of 
proinflammation (11).
C-reactive protein (CRP) has been 
shown to be associated with retinop-
athy (12). CRP has been used as a 
plasma measure of inf lammation, 
with evidence suggesting it may be 
a predictive marker of retinopathy 
among both diabetic and nondiabetic 
populations (13–15) although, nota-
bly, inflammation is higher among 
patients diagnosed with type 1 or 
type 2 diabetes (13,14). Alterations 
in retinal structure and function 
may present in individuals without a 
preexisting diagnosis of retinopathy. 
Risks common to retinal dysfunc-
tion include hypertension, abnormal 
lipid profile, and obesity (16). Physical 
activity and muscle-strengthening 
activity (MSA) are plausibly capable 
of improving inflammatory responses 
linked to retinopathy in both healthy 
and diseased populations. MSA may 
reduce fat mass and improve body 
composition (17), thus providing 
plausibility for strength training to 
improve the lipid profile and help 
with successful weight management 
and, ultimately, inflammatory regu-
lation. In addition, past work shows 
that aerobic-based physical activity 
substantially increases lipolysis (18) 
and reduces systemic inflammation 
(19). Although distinct in mecha-
nism of action and modality, physical 
activities involving both aerobic-based 
and MSA components may exert 
complementary health benefits on 
retinopathic prognosis and disease 
severity (20–26). However, we are 
unware of any study that has spe-
cifically evaluated the independent 
associations of aerobic-based physical 
activity and MSA on systemic inflam-
mation among adults with evidence 
of retinopathy. Therefore, the specific 
aim of this study was to evaluate the 
potential association of total physical 
activity and MSA on CRP, an estab-
lished biomarker of inflammation 
and retinopathy progression, among 
a sample of retinopathy patients.
Methods
Design 
Data from the 2005–2006 National 
Health and Nutrition Examination 
Survey (NHANES) was used. Study 
procedures were approved by the 
National Center for Health Statistics 
ethics review board, with informed 
consent obtained before data 
collection.
The NHANES is an ongoing 
survey conducted by the Centers for 
Disease Control and Prevention that 
uses a representative sample of non- 
institutionalized U.S. civilians selec- 
ted by a complex, multistage, strat-
ified, clustered probability design. 
The design consists of four stages, 
including the identification of coun-
ties, segments (city blocks), random 
selection of households within the 
segments, and random selection of 
individuals within the households. 
Further information on NHANES 
methodology and data collection is 
available on the NHANES website 
(www.cdc.gov/nchs/nhanes.htm). 
Participants
The analyzed sample included 157 
participants with complete data on 
the study variables who had evidence 
of mild or moderate-to-severe non-
proliferative retinopathy and who 
did not have a physician’s diagnosis 
of coronary artery disease, congestive 
heart failure, heart attack, or stroke; 
participants were excluded if they had 
these conditions because these param-
eters may have confounded our inves-
tigated association between physical 
activity and systemic inflammation 
among those with retinopathy. The 
participants ranged in age from 40 to 
85 years. 
Retinopathy
As we have described elsewhere 
(27,28), retinal imaging was per-
formed using the Canon Non-
Mydriatic Retinal Camera CR6-
45NM (Canon, Tokyo, Japan). The 
presence of nonproliferative retino- 
pathy (mild or moderate/severe ret-
inopathy) was determined using the 
Early Treatment Diabetic Retinopathy 
Study grading criteria (29). 
Systemic Inflammation
From a blood sample, CRP was as-
sessed as a marker of systemic in-
flammation. High-sensitivity CRP 
concentration was quantified using 
latex-enhanced nephelometry.
Measurement of Physical 
Activity
Physical activity was assessed for up 
to 7 days using an ActiGraph 7164 
accelerometer; activity counts/minute 
≥2,020 defined participation in 
moderate-to-vigorous physical activity 
(MVPA) (30), with individuals hav-
ing at least 4 days of ≥10 hours/day 
of monitoring included in the analy-
ses. Non–wear-time was identified as 
≥60 consecutive minutes of zero ac-
tivity counts, with allowance for 1–2 
minutes of activity counts between 
0 and 100. Specific details regarding 
the NHANES accelerometer protocol 
have been previously published (31).
Measurement of MSA
Participants were asked one to two 
questions related to engagement in 
MSA: 1) “Over the past 30 days, 
did you do any physical activities 
specifically designed to strengthen 
your muscles such as lifting weights, 
pushups, or sit-ups?” (response op-
tion: “yes” or “no”) and 2) individuals 
answering “yes” to the first question 
were then asked, “Over the past 30 
days, how many times did you do 
these activities designed to strengthen 
your muscles such as lifting weights, 
pushups, or sit-ups?” These exact 
NHANES MSA items have provided 
evidence of convergent validity (e.g., 
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were shown to be associated with 
cardiovascular-related parameters [32] 
and insulin sensitivity [33]). Further, 
we calculated knee extremity strength 
(using a Kin Com MP dynamometer) 
among individuals reporting and not 
reporting engagement in MSA (≥50 
years of age); individuals reporting 
engagement in MSA (unweighted 
mean: 296.9 N) had greater knee ex-
tensor strength than individuals not 
reporting engagement in MSA (un-
weighted mean: 266.0 N) (P <0.05), 
providing some evidence of construct 
validity for this MSA item. Notably, 
these estimates were not from the 
NHANES cycle in the present study 
(2005–2006) but rather were from the 
1999–2002 NHANES cycles because 
the 1999–2002 cycles are the only 
ones with lower-extremity strength 
data.
Analysis
All statistical analyses, computed in 
Stata version 12 (StataCorp., College 
Station, Tex.), accounted for the com-
plex survey design used in NHANES. 
A weighted multivariable linear re-
gression was used, with the outcome 
variable being CRP and the main in-
dependent variables being accelerometer- 
assessed MVPA (minutes/day) and 
MSA (number of sessions/month). 
This model also included the follow-
ing covariates: age (years; continu-
ous), sex, race/ethnicity (Mexican 
American, non-Hispanic white, 
non-Hispanic black, other), self- 
reported smoking status (current, for-
mer, never-smoker), measured BMI 
(continuous; kg/m2), diabetes status 
(yes/no), physician-diagnosed hyper-
tension (yes/no), objectively measured 
visual acuity (34) (normal vision, 
uncorrected refractive effort, and vi-
sion impairment), and objectively 
measured retinopathy status (mild/
moderate-to-severe). With regard to 
diabetes status, participants were de-
fined as having diabetes if they had 
a physician’s diagnosis, had a fasting 
blood glucose of ≥126 mg/dL, had 
an A1C ≥6.5%, or were taking any 
diabetes medications. Significance was 
set at P <0.05.
Results
Table 1 displays the weighted charac-
teristics of the sample. Participants, 
on average, were 56 years old; mean 
MVPA was 21.6 minutes/day; mean 
MSA was 5.1 sessions/month; mean 
CRP was 0.45 mg/dL; 70% had dia-
betes; and 87.7 and 12.3% had mild 
and moderate-to-severe retinopathy, 
respectively.
Regarding the main findings, only 
MVPA and not MSA was inde-
pendently associated with lower CRP 
among individuals in the retinopathy 
sample. In a model that only included 
MVPA and MSA as independent vari-
ables, MVPA (β = –0.007, 95% CI 
–0.01 to –0.005, P <0.001) but not 
MSA (β = –0.001, 95% CI –0.003 
to 0.0008, P = 0.23) was associated 
with CRP. In the adjusted model 
(Table 2), results were similar, in that 
MVPA (β = –0.004, 95% CI –0.007 
to –0.001, P = 0.006) but not MSA 
(β = –0.0001, 95% CI –0.002 to 
0.001, P = 0.86) was associated with 
lower CRP levels. For example, for a 1 
minute/day increase in MVPA, there 
was a corresponding 0.004 mg/dL 
decrease in CRP. When expressed as 
a larger interval change (30 minutes/
day), for a 30 minutes/day increase in 
MVPA, there was a corresponding 
0.12 mg/dL decrease in CRP.
A follow-up analysis expressed 
CRP as a binary variable, catego-
rized as elevated (≥0.3 mg/dL) or not 
(<0.3 mg/dL). In an adjusted logis-
TABLE 1. Weighted Characteristics of the Study Variables  
(n = 157)
Variable Point Estimate (SE) 
MVPA, mean minutes/day 21.6 (2.1)
MSA, mean sessions/month 5.1 (2.7)
Age, mean years 56.3 (1.6)
BMI, mean kg/m2 29.2 (0.4)
CRP, mean mg/dL 0.45 (0.1)
Sex, % female 42.9
Race/ethnicity, %
Non-Hispanic white 73.3
Current smoker, % 28.1
Diabetes, % 70.1
Hypertension, % 45.1






TABLE 2. Adjusted Regression Results Examining the Association Between Physical Activity and 
Muscle-Strengthening Activities on CRP
Linear Regression Logistic Regression
β 95% CI P OR 95% CI P
MVPA, minutes/day –0.004 –0.007 to –0.001 0.006 0.93 0.89–0.96 0.001
MSA, sessions/month 0.0001 –0.002 to 0.001 0.86 0.94 0.83–1.07 0.33
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tic regression model, for a 1 minute/
day increase in MVPA, retinopathy 
patients had a 7% reduced odds of 
having an elevated CRP (odds ratio 
[OR] 0.93, 95% CI 0.89–0.96, 
P = 0.001). When expressed as a larger 
interval change, for a 30 minutes/ 
day increase in MVPA, there was a 
corresponding 88% reduced odds of 
having an elevated CRP (OR 0.12, 
95% CI 0.04–0.39; P = 0.001).
Discussion
Previous research highlights the at-
tenuating benefit of physical activ-
ity on inflammatory mechanisms 
in healthy and diseased populations 
(17,19,25,26). Therefore, the pur-
pose of our study was to extend this 
literature by examining the association 
of MSA and accelerometer-assessed 
physical activity on CRP among indi-
viduals with retinopathy because ele-
vated systemic inflammation has been 
shown to facilitate the progression of 
retinopathy disease (14–16,35). Our 
main finding was that, among indi-
viduals engaging in higher levels of 
MVPA, CRP levels were reduced, 
whereas participation in MSA did 
not have a statistically significant in-
fluence on CRP.
Our findings demonstrate that 
even modest increases in physical 
activity may have a positive impact 
on retinopathic outcomes. For every 
additional 30-minute increase in 
MVPA, there was an associated 
0.12 mg/dL decrease in CRP and 
an 88% reduced odds of having an 
elevated CRP. β-Adrenergic recep-
tors are suggested to stimulate fat 
cells and increase pro-inflammation 
by way of cytokine mobilization 
(36,37). Physical activity may alter β- 
adrenergic receptor density and 
expression, curtailing their stimu-
latory effect on adipose tissue (38). 
Another possible mechanism by 
which this interaction may develop 
is the association between physical 
activity and stress reduction. High 
levels of stress may accelerate depres-
sion and anxiety, and the release of 
pro-inflammatory cytokines (39–41). 
A stronger clinical approach should 
perhaps focus on limiting retinopathy 
progression with physical activity in 
combination with individual stress- 
management strategies.
MSA data were self-reported, 
which augments the need for 
increased sample size to maximize 
potential for statistical significance, 
as questionnaire-based estimations 
tend to foreshadow weakened effect 
size (42). In addition to the risk of 
erroneous estimations in subjectively 
reported data, another potential 
explanation for the negligible influ-
ence of MSA on CRP status is the low 
frequency of resistance-training par-
ticipation reported by participants in 
the present sample. On average, par-
ticipants engaged in only five sessions 
of MSA per month, which is likely 
insufficient to favorably mitigate 
inflammation. The American College 
of Sports Medicine and the American 
Heart Association recommend engag-
ing in at least two sessions of MSA 
per week for optimal health benefits, 
particularly among aging individuals 
(43,44). Future work should examine 
associations between MSA and reti-
nopathy, with participant adherence 
to appropriate levels of activity closely 
monitored. 
In conclusion, this study identifies 
the association between accelerometer- 
assessed MVPA participation and 
lower plasma measures of CRP 
among aging individuals with a non-
proliferative retinopathy diagnosis. 
Our findings amplify important 
conclusions from previous research 
suggesting the multifactorial impact 
of physical activity on retinopathic 
biomarkers. We specifically examined 
the plausibility for aerobic-based, as 
well as resistance training, modalities 
to reduce concentration of plasma 
CRP among people with existing 
retinopathy. We identified a relation-
ship between MVPA engagement 
and CRP reduction. This finding is 
noteworthy because elevated inflam-
mation may facilitate retinopathy 
disease progression (14–16,35,45). 
Our use of a cross-sectional research 
design, in addition to self-reported 
MSA, are limitations that should 
be addressed in future longitudinal 
investigations. 
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